This study is in progress, not accepting new patients
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Follicular Lymphoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Orange 5379513, California 5332921 and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Regeneron Pharmaceuticals
- Links
- OLYMPIA
- ID
- NCT06091254
- Phase
- Phase 3 Lymphoma Research Study
- Study Type
- Interventional
- Participants
- About 462 people participating
- Last Updated